The problem is the 2 drugs that have completed Phase II they have been unable to find anybody that's wants to license them for a very long time ….. despite great (?) data ?
1102 for MS - Teva handed back almost 10 years ago after Phase II completion …
Got another shot with TJAB striking a deal few years later but they too handed it back.
1103 for Acromegaly - Cortendo licensed it on Phase II data almost 5 years ago and then handed it back not long after.
It's all about DMD and hopefully achieving better outcomes over the next few years when they get to a Phase IIb trial.
Two drugs in phase 2 and one in Phase 2b, page-2
-
- There are more pages in this discussion • 148 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
